Background Pregnancies have been reported after endometrial ablation but there is little data regarding subsequent pregnancy outcomes.
Introduction
Endometrial ablation is a widely used minimally invasive treatment of menorrhagia that reduces abnormal uterine bleeding by destroying the stratum functionalis of the endometrium. Prior to the advent of ablation, hysterectomy was often performed if medical management could not satisfactorily control menorrhagia; compared with hysterectomy, ablation is associated with lower morbidity, recovery time and cost. 1 First-generation techniques are performed under hysteroscopic visualisation and include transcervical loop resection, rollerball ablation, and laser ablation. Second-generation techniques do not require hysteroscopy and are easier to perform with similar rates of efficacy and complications. 2 Second-generation methods that have been or are available globally include thermal balloon ablation, hydrothermal ablation, cryoablation, microwave ablation, and radiofrequency ablation.
Although most endometrium is obliterated, if functional endometrium remains or is regenerated after ablation, pregnancy is possible. Post-ablation pregnancy has been associated with poor outcomes including miscarriage, intrauterine growth restriction (IUGR), preterm delivery, adherent placentation, and perinatal mortality. 3 Previous studies have suggested a post-ablation pregnancy rate of 0.24-5.2%, depending on the ablation technique and the cohort studied. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] No systematic reviews have been published on this topic. Our objective was systematically to review the evidence regarding characteristics and outcomes of pregnancies after endometrial ablation, in order to equip physicians effectively to counsel and manage women considering endometrial ablation.
Methods

Study design
The protocol for this systematic review was based on the Preferred Reporting Items for Systematic Review & MetaAnalysis Protocols, 13 and was registered in the PROSPERO database (CRD4201604808, available at www.crd.york.ac. uk/prospero). The protocol included objective, search strategies, eligibility criteria, outcomes of interest, and study quality assessment.
Search strategy and study selection
We performed a comprehensive review of the published literature and grey literature (reports and documents not published commercially, which may include conference proceedings, white papers, doctoral theses/dissertations, and other sources) 14, 15 by systematically searching MED-LINE, Embase, the Cochrane Library, and ClinicalTrials. gov from database inception through January 2017 to identify reports that described one or more pregnancies in women who had previously undergone endometrial ablation. Terms for the systematic search focused on endometrial ablation or endometrial resection, pregnancy, and morbidly adherent placenta; the complete search strategy is shown in Supporting Information Appendix S1.
Abstracts, case reports, case series, cohort studies, uncontrolled device studies, randomised and non-randomised controlled trials, unpublished trials, and data from major ablation device manufacturers were eligible for inclusion. We included sources in any language. Additional studies were identified by examining the references of select articles, as recommended by the Cochrane Handbook for Systematic Reviews. 16 Two trained reviewers (J.R.K. and K.A.F.) screened titles and abstracts, as well as reviewed the full text of selected studies, to assess satisfaction of eligibility criteria. Any discrepancies between reviewers were resolved by discussion. A flow diagram for study selection appears in Figure 1 .
Data extraction
Data was extracted independently by two trained investigators (J.R.K. and K.A.F.) using a standardised form. Discrepancies were resolved by discussion or adjudication of a third reviewer (X.G.). When several reports described the same pregnancy, the most comprehensive was used; duplicate reports were excluded from the final count of reported pregnancies, but are listed for reference in Supporting Information Table S5 . For all non-case report studies, we contacted authors to inquire whether missing data were available, in accordance with the Cochrane Handbook for Systematic Reviews. 16 The following information was extracted when available for each pregnancy reported: first author, year, study design, modality of ablation, post-ablation menses, postablation contraception, time between ablation and conception, maternal age at conception, gestational age at pregnancy diagnosis, gestational age at pregnancy conclusion, mode of delivery, birthweight, placental adherence, timing and estimated blood loss of haemorrhage, and any adverse maternal or neonatal outcomes.
In the coding process, we used the following definitions. We coded the study design as a case report if it described one or two cases of pregnancy, and as a case series if it described three or more cases of pregnancy. Menses was classified as light (diminished flow compared to pre-ablation menses), normal (no change in flow), present (menses present, but heaviness not described) or irregular if that term was used by the author(s). Maternal age at pregnancy and duration of time between ablation and conception were extracted when available, or calculated if information was provided. Miscarriage was defined as non-elective pregnancy termination prior to 20 weeks; intrauterine fetal demise (IUFD) was defined as fetal demise at or after 20 weeks or >500 g. For gestational age at the end of pregnancy, we included weeks when available or used the term employed by the authors (full term was coded as ≥37 weeks, preterm was coded as <37 weeks). Placentation was classified as accreta, increta or percreta if this language was used by the original report. If the placenta was reported as adherent or did not deliver easily, but pathology was unavailable, we classified it as adherent. If stated that the placenta was 'normal' or 'delivered easily', we classified it as normal.
Data synthesis
Analyses were performed using STATA Version 14.1 (College Station, TX, USA). Results were grouped by study design, separating case reports and case series from observational and experimental study designs. Within each group, data were tabulated separately for viable and previable pregnancies, using 24 weeks as the limit of viability. We used the Shapiro-Wilk test to assess normality before calculating measures of central tendency (P > 0.05 suggests data are normally distributed). Normal data are reported as mean AE SD and non-normal data as median and interquartile range (IQR).
Assessment of data quality
Two trained investigators (J.R.K. and K.A.F.) assessed study quality using the United States Preventive Services Task Force (USPSTF) rating criteria. We did not use another method to assess risk of bias (e.g. the Newcastle-Ottawa Scale or the GRADE criteria), as these do not apply to case reports/series.
Results
Availability of evidence
We identified 99 sources describing 274 unique cases of pregnancy after endometrial ablation. Reports appeared between 1991 and 2016 and consisted of 15 abstracts, 82 manuscripts, and two reports for which the original source was unavailable (Figure 1 ). There were 21 sources that reported one or more pregnancies as an outcome of an investigational or observational research study, while the remaining 78 sources were limited to case reports or case series. Using the USPSTF quality rating criteria, there were six study designs of Level I evidence, 15 study designs of Level II evidence, and 78 study designs of Level III evidence. However, the primary outcomes of Level I and II studies were effectiveness and safety of ablation to treat menorrhagia, with limited data assessing pregnancy as a long-term complication; this significantly limits the level of evidence with regard to our clinical question, effectively restricting the best available evidence to Level II and III.
Of the reports of pregnancies in the literature, 94% provided additional information about the preconception interval and/or the pregnancy outcome (n = 258). Preconception characteristics and pregnancy outcomes are summarised in Tables 1 and 2 , respectively.
Evidence tables include detailed information about each reported pregnancy. Viable and previable pregnancies reported by randomised controlled trials, non-randomised but controlled trials, uncontrolled studies, and cohort studies (n = 132) are shown in Supporting Information  Table S1 . Pregnancies that appeared as part of case reports or case series are grouped by viability; those ending prior to viability (n = 68) appear in Supporting Information Table S2 , and viable pregnancies (n = 58) are detailed in Supporting Information Table S3 . Pregnancies without known outcomes (n = 16) are in Supporting Information Table S4 .
Trials and cohort studies
Of the 132 pregnancies reported as part of a trial/observational study, 83% (n = 110) occurred after a first-generation technique and 17% (n = 22) after a second-generation technique. Transcervical loop resection was the modality of ablation for 65% of pregnancies (n = 86) reported by trial/ observational studies.
Post-ablation menstruation was only described for 8% of the pregnancies (n = 10), of which eight had continued menstruation and two were amenorrhoeic. Contraception after ablation was described by only 7% of pregnancies (n = 9): eight occurred after no contraception, and one pregnancy was intended. Nearly half of pregnancies reported by trial/observational studies (n = 65) noted the duration of time between ablation and conception; pregnancies occurred after a median of 1.5 and 2 years, ranging from 6 months to 6 years. Maternal age at conception was reported for 15% of pregnancies in trial/observational studies (n = 20): pregnancies were conceived at a mean maternal age of 37 and 40 years, ranging from 33 to 50 years of age. Only two pregnancies noted gestational age at pregnancy diagnosis (8 weeks and 12 weeks of gestation).
Of the 132 pregnancies reported as part of a trial/observational study, 79% (n = 104) ended in either termination of pregnancy or miscarriage. There were eight ectopic pregnancies (6%) and one IUFD (1%). Trial/observational studies reported 18 deliveries (14%), including nine caesarean deliveries, five vaginal deliveries, and four caesarean hysterectomies. Additionally, three pregnancies were terminated by caesarean hysterectomy. Of 15 pregnancies reporting birthweight, two (13%) weighed <2500 g. Trial/ observational studies reported three pregnancies with morbidly adherent placenta (2%).
There were two notable pregnancies reported by trials/ observational studies. One had PPROM at 22 weeks complicated by chorioamnionitis, followed by delivery of a lowbirthweight infant at 33 weeks via caesarean hysterectomy due to placenta increta with subsequent neonatal demise. The other had PPROM at 32 weeks, delivered by caesarean complicated by uterine synechiae -the women developed severe endometritis and underwent postpartum hysterectomy on day 5.
Case reports
Of the 126 pregnancies appearing in a case report or case series, 71% (n = 90) occurred after a first-generation technique, 19% (n = 24) occurred after a second-generation technique, and 10% (n = 12) did not report the method of ablation. For pregnancies appearing in case reports, transcervical loop resection, laser ablation, and thermal balloon ablation were the most common methods of ablation.
Post-ablation menstrual patterns were described by 55% of pregnancies from case reports (n = 69). Seventeen pregnancies experienced amenorrhoea after ablation, and 52 had some form of menstruation.
Of pregnancies appearing in case reports/series, 40% described contraception after ablation (n = 51). Notably, six pregnancies occurred while the woman was using contraception (two using progestin-only pills and four with some form of tubal sterilisation). In all, 40 pregnancies reported by case reports/series occurred while the woman was not using any contraception, of whom six had a long history of infertility prior to ablation. Lastly, five pregnancies were intended (tubal reanastomosis or in vitro fertilisation).
Case reports described pregnancies occurring a median of 1.2-1.5 years after endometrial ablation, but conception ranged from a few weeks prior to ablation up to 13 years after ablation -a much wider range than those pregnancies reported by trial/observational studies. Mean maternal age in case reports was 39 years for previable pregnancies and 36 years for viable pregnancies, and ranged from 26 to 50 years.
The 75th percentile for gestational age at the time of pregnancy diagnosis in case reports was 12 weeks for previable pregnancies and 16 weeks for viable pregnancies -but was as late as 30 weeks in one case. Overall, most pregnancies in case reports were diagnosed by 8-12 weeks of gestation.
Of the 126 pregnancies reported in a case report/series, 44% (n = 55) ended in elective termination or miscarriage. There were eight IUFDs (6%), five deliveries of a previable fetus (4%), four ectopic pregnancies (3%), and one molar pregnancy (1%). In all, 42% (n = 53) of pregnancies described in case reports/series ended in delivery of a viable fetus, of which 55% (n = 29) were delivered preterm. Case reports/series described the birth of 28 healthy neonates (22%). However, adverse outcomes were also more common in case reports/series than in trial/observational studies ( Table 2 ): 14 reported cases of PPROM, ten infants with IUGR, seven uterine ruptures, five cases with a congenital malformation, and three demises of a viable neonate. Of the 37 post-ablation pregnancies in a case report that described birth weight, 49% (n = 18) were less than 2500 g. 
CD, caesarean delivery; Gest sac, gestational sac; IQR, interquartile range; IUFD, intrauterine fetal demise; IUGR, intrauterine growth restriction; g, grams; MAP, morbidly adherent placenta; n, number; PPROM, preterm premature rupture of membranes; SVD, spontaneous vaginal delivery; VBAC, vaginal birth after caesarean.
In case reports/series, 65 pregnancies noted the method of delivery: 23 caesarean hysterectomies, 27 caesarean deliveries, 12 vaginal deliveries, and seven hysterectomies (four followed vaginal or caesarean delivery to manage postpartum haemorrhage). The exceptionally high rates of caesarean (50/65, 77%) and hysterectomy (30/65, 46%) likely occurred in case reports/series due to the elevated prevalence of morbidly adherent placentas in these reported pregnancies. Of the 126 pregnancies in case reports/series, 23% (n = 29) had a morbidly adherent placenta (15 accreta, ten increta, four percreta). These pregnancies were often complicated by haemorrhage, ranging from 1.5 to 12 l.
Morbidly adherent placenta (MAP)
Overall, in 258 post-ablation pregnancies reported by trials, observational studies, and case reports, there were 32 reported cases of morbidly adherent placenta: 3/132 pregnancies in trial/observational studies and 29/126 pregnancies in case reports. Together, this is an approximate rate of MAP of 12% in all reported post-ablation pregnancies. Of the reported MAP pregnancies, 26 ended in caesarean hysterectomy or hysterectomy, and 13 were complicated by haemorrhage. We examined the reported MAP pregnancies for risk factors that may have contributed to the development of MAP (in addition to endometrial ablation) -specifically previous caesarean, current placenta praevia, in vitro fertilisation (IVF), other uterine surgery, and advanced maternal age. 17 Risk factors for each reported MAP pregnancy are shown in Table S5 ; 19 were born to women of advanced maternal age, six had a history of prior caesarean, four had a history of other uterine surgery (dilation and curettage, myomectomy), three had a placenta praevia, and only one had conceived using IVF.
Discussion
Main findings
This systematic review summarises pregnancies after endometrial ablation reported in the literature. To date, we have identified 274 cases. First-generation endometrial ablation techniques were significantly more common than secondgeneration techniques in both case report and non-case report sources. Of the 79 reported pregnancies describing menstrual status, 76% occurred in a woman with continued menstruation; of the 61 reported pregnancies describing contraceptive use, 80% occurred in a woman without adequate contraception. Six reported pregnancies were intended; all required physician involvement to conceive (permanent sterilisation reversal or in vitro fertilisation). Only two pregnancies in trial/observational studies mentioned gestational age at diagnosis, limiting our ability to assess the frequency of delayed pregnancy diagnosis; however, in case reports, more than 25% of pregnancies were diagnosed at or after 14 weeks.
Outcomes were somewhat similar between differing study designs. In trial/observational studies, 85% of reported pregnancies ended in termination, miscarriage or were ectopic; 20 pregnancies continued with high rates of preterm delivery (33%), caesarean delivery (50%), and caesarean hysterectomy (22%), as well as three cases of MAP. In case reports, 47% of reported pregnancies ended in termination, miscarriage, or were ectopic; of the 66 pregnancies that continued, 52% delivered preterm, 44% delivered by caesarean, and 37% delivered by caesarean hysterectomy. There were 29 cases of morbidly adherent placenta.
Strengths and limitations
Our study has important limitations. Half of the pregnancies were reported by case reports/series and described pregnancies in detail; half were reported by trial/observational studies with limited or missing information. Thus, we are unable conclusively to summarise patterns of menstruation and contraception that contribute to the risk of post-ablation pregnancy. Additionally, it is important to note that women seek endometrial ablation to treat menorrhagia; the aetiology of menorrhagia may predispose women to adverse pregnancy outcomes including miscarriage or preterm birth, especially in cases of adenomyosis or uterine fibroids. The vast majority of reported pregnancies did not describe the aetiology of menorrhagia. Lastly, there is a potential for publication bias. Trial/observational studies reported only a few pregnancies that continued to delivery (with limited data about outcomes), whereas case reports may favour the most complex cases with a wide variety of outcomes. As it is probable that uncomplicated pregnancies after endometrial ablation are underreported, publication bias likely overestimates the risk of adverse outcomes.
Regarding strengths, this is the first review to ascertain the number of pregnancies after endometrial ablation reported in accessible literature, and the first systematically to evaluate and summarise characteristics of women who become pregnant and subsequent pregnancy outcomes. This information equips physicians effectively to counsel and manage women considering endometrial ablation and any women who become pregnant after ablation.
Interpretation
The relation between menstrual status after endometrial ablation and subsequent pregnancy warrants consideration. Post-ablation menstruation appears to depend on ablation modality, with rates of amenorrhoea at 12 months ranging from 8% with thermal balloon ablation to 59% with Novasure â . 18 We found that first-generation techniques were more common than second-generation techniques, and postulate that first-generation techniques may have less completely ablated the endometrium, with lower rates of post-ablation amenorrhoea and concomitant higher risk for subsequent pregnancy. Furthermore, some studies suggest that focal or global regeneration of the endometrium is possible, [19] [20] [21] [22] [23] which may have contributed to the pregnancies conceived many years after endometrial ablation. However, it is important to note that (when menses was described) one-quarter of women who became pregnant after ablation were amenorrhoeic; thus, contraception remains necessary in women without menses and essential in women with continued menstruation, in order to prevent unintended post-ablation pregnancy. Lastly, although device companies are required by the Food & Drug Administration to provide an avenue for reporting procedural complications, no true surveillance exists to detect pregnancy after ablation. A registry of endometrial ablations may not be feasible, 24 but, at least to improve upon data quality, we recommend that all future studies of endometrial ablation and pregnancy specifically describe post-ablation menstruation and contraception as well as pregnancy outcomes.
Morbidly adherent placentation was strikingly common, and reported cases had additional morbidities such as haemorrhage, caesarean delivery, caesarean hysterectomy, and postpartum hysterectomy. The estimated rate of MAP in all women is 0.02% in the UK 17 and 0.14% in the USA; 25 MAP may be as frequent as 5.77% in pregnancies with both previous caesarean and current placenta praevia. 17 Our systematic review indicates that 2.3% (3/132) of pregnancies reported by trials/observational studies and 23.0% (29/126) of pregnancies reported in case reports/series had MAP. Nineteen (60%) were conceived in a woman of advanced maternal age, but only six (19%) reported prior caesarean and three (9%) reported placenta praevia. Although case reports likely exaggerate the risk of MAP due to publication bias and ablation was not the only risk factor for MAP in some reported pregnancies, it seems that a history of ablation is a risk factor for MAP in subsequent pregnancy, particularly due to the large proportion of women who had MAP after ablation but no prior caesarean delivery.
It has been suggested previously that as abnormal placentation is so prevalent in post-ablation pregnancies and risks significant consequences, any pregnancy after ablation should be assumed to have an adherent placenta until proven otherwise. [26] [27] [28] [29] We recommend that pregnancies with a history of ablation be cared for in a setting with the multidisciplinary capacity and experience to identify and manage MAP if present.
As it is within the right of a woman to pursue pregnancy after endometrial ablation if appropriately informed of the risks, we strongly recommend that physicians undertake and document thorough counselling before endometrial ablation. This should include: 1 the known risks of post-ablation pregnancy, focusing on outcomes described by trial/observational studies, while acknowledging the potential complications presented by case reports (understanding the risk of publication bias); 2 the importance of reliable contraception after the procedure, even if amenorrhoeic, perimenopausal, or previously treated for infertility; 3 the alternatives to pregnancy after endometrial ablation, including: alternative methods to treat abnormal uterine bleeding such as levonorgestrel-containing intrauterine devices, delaying ablation until completion of childbearing, and surrogacy or adoption. Additionally, if a woman becomes pregnant after ablation and chooses to continue her pregnancy following appropriate counselling (informing her of the known risks from both trials/observational studies and case reports), we recommend appropriate caution in counselling about mode of delivery.
Conclusion
While rare, pregnancy after endometrial ablation remains a significant event due to the potential severity of associated complications, including premature delivery, morbidly adherent placentation, uterine rupture, caesarean delivery and caesarean hysterectomy, and perinatal mortality. Prior to undergoing endometrial ablation, women should be informed that subsequent pregnancy may have serious complications and must be advised to use a reliable form of contraception even through perimenopause. Delayed diagnosis of post-ablation pregnancy was not uncommon, therefore we urge physicians to maintain a high index of suspicion for pregnancy in any woman who has undergone ablation, regardless of her post-ablation menstrual patterns. Lastly, any pregnancies with a known history of endometrial ablation should receive timely referral to an appropriate specialist for evaluation of placental adherence and subsequent delivery management. References 30-105 are related to the supplementary evidence tables detailing each included study. work, revised the manuscript for important intellectual content, provided final approval for publication, and agreed to be accountable for all aspects of the work.
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